Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free AGX Stock Alerts

Argan (AGX) Financials

Argan logo
$623.10 +34.20 (+5.81%)
Closing price 03:59 PM Eastern
Extended Trading
$620.50 -2.60 (-0.42%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Argan

Annual Income Statements for Argan

This table shows Argan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 36 70 72 52 -43 24 38 33 32 83 145
Consolidated Net Income / (Loss)		 50 77 72 52 -41 24 36 35 32 85 138
Net Income / (Loss) Continuing Operations		 50 77 72 52 -41 24 36 35 32 85 138
Total Pre-Tax Income 		76 115 113 47 -48 25 47 46 49 111 161
Total Operating Income		 74 112 107 40 -56 23 45 42 36 88 135
Total Gross Profit		 99 147 149 82 -6.82 62 100 86 81 141 194
Total Revenue		 413 675 893 482 239 392 509 455 573 874 945
Operating Revenue		 413 675 893 482 239 392 509 455 573 874 945
Total Cost of Revenue		 314 528 743 400 246 330 410 369 492 733 751
Operating Cost of Revenue		 314 528 743 400 246 330 410 369 492 733 751
Total Operating Expenses		 25 34 42 42 49 39 55 45 44 53 59
Selling, General & Admin Expense		 25 32 42 41 44 39 47 45 44 53 59
Total Other Income / (Expense), net		 1.10 2.28 5.65 6.98 8.08 1.86 2.55 4.33 12 23 26
Other Income / (Expense), net		 1.10 2.28 5.65 6.98 8.08 1.86 2.55 4.33 12 23 26
Income Tax Expense		 25 37 40 -4.65 -7.05 1.07 11 11 17 26 23
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - 0.00 0.00 0.72 2.94 -7.36
Basic Earnings per Share		 $2.46 $4.67 $4.64 $3.34 ($2.73) $1.52 $2.43 $2.35 $2.42 $6.35 $10.00
Weighted Average Basic Shares Outstanding		 14.76M 15.07M 15.52M 15.57M 15.62M 15.67M 15.72M 14.08M 13.37M 13.45M 13.77M
Diluted Earnings per Share		 $2.42 $4.50 $4.56 $3.32 ($2.73) $1.51 $2.40 $2.33 $2.39 $6.15 $9.74
Weighted Average Diluted Shares Outstanding		 15.02M 15.63M 15.78M 15.69M 15.62M 15.83M 15.91M 14.18M 13.55M 13.91M 14.15M
Weighted Average Basic & Diluted Shares Outstanding		 14.80M 15.10M 15.50M 15.60M 15.64M 15.72M 14.82M 13.40M 13.24M 13.63M 13.95M
Cash Dividends to Common per Share		 $0.70 $1.00 $1.00 $1.00 $1.00 $3.00 $1.00 $1.00 $1.10 $1.35 $1.75

Quarterly Income Statements for Argan

This table shows Argan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 4.16 14 6.12 19 26 33 29 34 32 50 43
Consolidated Net Income / (Loss)		 5.46 12 7.88 18 28 31 23 35 31 49 46
Net Income / (Loss) Continuing Operations		 5.46 12 7.88 18 28 31 23 35 31 49 46
Total Pre-Tax Income 		12 17 11 24 37 39 30 36 40 55 54
Total Operating Income		 7.86 12 6.52 19 30 33 24 30 33 48 45
Total Gross Profit		 19 24 18 31 44 48 37 44 47 66 61
Total Revenue		 164 165 158 227 257 232 194 238 251 262 291
Operating Revenue		 164 165 158 227 257 232 194 238 251 262 291
Total Cost of Revenue		 145 141 140 196 213 185 157 193 204 196 230
Operating Cost of Revenue		 145 141 140 196 213 185 157 193 204 196 230
Total Operating Expenses		 11 12 11 12 14 15 13 14 14 18 16
Selling, General & Admin Expense		 11 12 11 12 14 15 13 14 14 18 16
Total Other Income / (Expense), net		 3.73 5.25 4.79 5.60 6.65 5.97 5.44 5.58 7.06 7.72 8.37
Other Income / (Expense), net		 3.73 5.25 4.79 5.60 6.65 5.97 5.44 5.58 7.06 7.72 8.37
Income Tax Expense		 6.13 4.96 3.43 6.08 8.97 7.26 7.24 0.36 8.96 6.18 7.71
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 1.31 -1.97 1.76 -1.27 1.62 -1.48 -6.30 1.33 -1.46 -0.93 3.20
Basic Earnings per Share		 $0.41 $0.90 $0.59 $1.36 $2.07 $2.33 $1.65 $2.57 $2.22 $3.56 $3.30
Weighted Average Basic Shares Outstanding		 13.33M 13.37M 13.26M 13.40M 13.53M 13.45M 13.63M 13.73M 13.83M 13.77M 13.96M
Diluted Earnings per Share		 $0.40 $0.89 $0.58 $1.31 $2.00 $2.26 $1.60 $2.50 $2.17 $3.47 $3.24
Weighted Average Diluted Shares Outstanding		 13.56M 13.55M 13.57M 13.88M 14.03M 13.91M 14.11M 14.13M 14.16M 14.15M 14.20M
Weighted Average Basic & Diluted Shares Outstanding		 13.33M 13.24M 13.35M 13.50M 13.58M 13.63M 13.64M 13.81M 13.87M 13.95M 14.02M
Cash Dividends to Common per Share		 $0.30 $0.30 $0.30 $0.30 $0.38 $0.38 $0.38 $0.38 $0.50 $0.50 $0.50

Annual Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents		 -173 6.37 -48 43 3.05 199 -16 -177 23 -52 194
Net Cash From Operating Activities		 -33 259 -73 -112 54 176 28 -30 117 168 415
Net Cash From Continuing Operating Activities		 -33 259 -73 -112 54 176 28 -30 117 168 415
Net Income / (Loss) Continuing Operations		 50 77 72 52 -41 24 36 35 32 85 138
Consolidated Net Income / (Loss)		 50 77 72 52 -41 24 36 35 32 85 138
Depreciation Expense		 0.78 2.04 2.78 3.42 3.51 3.72 3.37 2.98 2.01 1.91 1.91
Amortization Expense		 0.53 1.16 1.03 1.01 1.14 0.90 0.87 2.55 1.91 3.76 4.26
Non-Cash Adjustments To Reconcile Net Income		 2.23 118 -131 -42 34 12 39 -16 -18 25 -8.77
Changes in Operating Assets and Liabilities, net		 -87 60 -18 -127 56 136 -51 -54 99 51 280
Net Cash From Investing Activities		 -131 -244 39 171 -36 67 -7.04 -63 -68 -194 -182
Net Cash From Continuing Investing Activities		 -131 -244 39 171 -36 67 -7.04 -63 -68 -194 -182
Purchase of Property, Plant & Equipment		 -3.12 -2.81 -4.83 -8.60 -7.06 -1.70 -1.42 -3.37 -2.76 -6.58 -3.88
Acquisitions		 -17 - - - 0.00 -1.33 -5.62 0.00 -5.11 -16 -12
Purchase of Investments		 -252 -595 -543 -191 -195 -100 -90 -250 -219 -315 -377
Sale and/or Maturity of Investments		 138 354 588 370 166 170 90 190 160 149 210
Other Investing Activities, net		 3.96 - -1.50 0.23 - - - 0.00 0.00 -5.02 0.00
Net Cash From Financing Activities		 -8.65 -8.86 -14 -16 -14 -45 -35 -83 -26 -26 -43
Net Cash From Continuing Financing Activities		 -8.65 -8.86 -14 -16 -14 -45 -35 -83 -26 -26 -43
Repurchase of Common Equity		 - - - - 0.00 0.00 -20 -68 -12 -1.52 -9.88
Payment of Dividends		 -10 -25 -17 -16 -16 -47 -16 -15 -15 -18 -24
Other Financing Activities, net		 1.73 16 3.16 0.10 1.63 1.64 1.43 0.07 1.10 -6.27 -8.44
Effect of Exchange Rate Changes		 -0.57 - - - -0.47 1.73 -2.97 -0.54 -0.12 0.32 4.11
Cash Income Taxes Paid		 26 37 44 - - - 14 6.67 14 31 30

Quarterly Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
Net Change in Cash & Equivalents		 -19 11 11 25 -57 -30 44 -11 128 33 16
Net Cash From Operating Activities		 58 25 18 73 32 45 35 35 172 172 113
Net Cash From Continuing Operating Activities		 58 25 18 73 32 45 35 35 172 172 113
Net Income / (Loss) Continuing Operations		 5.46 12 7.88 18 28 31 23 35 31 49 46
Consolidated Net Income / (Loss)		 5.46 12 7.88 18 28 31 23 35 31 49 46
Depreciation Expense		 0.49 0.49 0.48 0.46 0.43 0.53 0.42 0.49 0.51 0.50 0.56
Amortization Expense		 0.10 1.61 0.65 0.10 0.10 3.46 1.17 0.98 0.94 1.17 1.62
Non-Cash Adjustments To Reconcile Net Income		 -2.87 -23 -4.93 11 3.65 15 -1.75 8.86 -13 -2.47 8.63
Changes in Operating Assets and Liabilities, net		 55 33 14 44 -0.41 -5.59 13 -11 154 124 57
Net Cash From Investing Activities		 -70 -5.72 -1.73 -43 -82 -67 25 -39 -37 -131 -67
Net Cash From Continuing Investing Activities		 -70 -5.72 -1.73 -43 -82 -67 25 -39 -37 -131 -67
Purchase of Property, Plant & Equipment		 -1.11 -0.61 -0.32 -2.35 -2.55 -1.37 -0.40 -1.69 -0.58 -1.21 -2.43
Purchase of Investments		 -69 - -87 -55 -102 -70 -40 -77 -85 -174 -93
Sale and/or Maturity of Investments		 - - 89 15 23 23 65 40 60 45 28
Net Cash From Financing Activities		 -5.56 -8.00 -5.12 -5.56 -6.93 -8.45 -18 -6.93 -7.52 -10 -34
Net Cash From Continuing Financing Activities		 -5.56 -8.00 -5.12 -5.56 -6.93 -8.45 -18 -6.93 -7.52 -10 -34
Repurchase of Common Equity		 -1.73 -4.00 -0.19 - -0.46 -0.88 -6.85 -0.20 - -2.83 -2.96
Payment of Dividends		 -3.99 -4.00 -4.03 -4.04 -5.20 -5.01 -5.07 -5.18 -7.05 -6.98 -7.01
Other Financing Activities, net		 0.16 -0.01 -0.91 -1.52 -1.28 -2.56 -6.08 -1.55 -0.47 -0.34 -24
Effect of Exchange Rate Changes		 -1.04 0.59 -0.13 -0.15 0.10 0.51 1.78 0.09 0.61 1.63 4.11

Annual Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets		 410 644 543 477 488 603 554 489 598 836 1,186
Total Current Assets		 351 588 485 416 422 546 507 439 547 781 1,132
Cash & Equivalents		 161 167 122 164 167 367 350 174 197 145 339
Short-Term Investments		 114 356 312 132 160 90 90 152 215 380 556
Accounts Receivable		 64 55 26 36 37 29 27 50 47 176 134
Other Current Assets		 4.08 3.19 25 84 57 61 40 63 87 80 104
Plant, Property, & Equipment, net		 12 13 15 20 23 20 10 10 11 14 17
Total Noncurrent Assets		 47 43 42 41 43 36 32 40 40 40 38
Goodwill		 37 35 34 33 28 28 28 28 28 28 28
Intangible Assets		 9.34 8.18 7.15 6.14 5.00 4.10 3.32 2.61 2.22 1.83 1.45
Other Noncurrent Operating Assets		 0.12 0.09 0.43 0.29 2.41 3.76 - 6.02 7.52 10 8.02
Total Liabilities & Shareholders' Equity		 410 644 543 477 488 603 554 489 598 836 1,186
Total Liabilities		 188 352 185 82 147 280 228 209 307 484 724
Total Current Liabilities		 188 351 183 81 144 276 223 203 302 480 711
Accounts Payable		 46 102 100 40 35 53 42 56 39 97 108
Accrued Expenses		 35 40 35 33 36 51 53 50 82 83 90
Other Current Liabilities		 - - 48 8.35 73 172 128 96 181 299 514
Total Noncurrent Liabilities		 0.22 1.20 1.28 0.96 2.48 4.14 4.96 6.09 5.03 4.51 13
Noncurrent Deferred & Payable Income Tax Liabilities		 0.22 1.20 1.28 - - - - - - 0.00 6.56
Other Noncurrent Operating Liabilities		 - - - 0.96 2.48 4.14 - 6.09 5.03 4.51 6.28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 222 293 358 394 341 322 326 281 291 352 462
Total Preferred & Common Equity		 219 292 358 395 339 321 326 281 291 352 462
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 219 292 358 395 339 321 326 281 291 352 462
Common Stock		 120 138 146 147 151 156 161 165 167 171 170
Retained Earnings		 100 155 211 248 189 166 189 208 226 293 406
Treasury Stock		 - - - - - -0.03 -20 -89 -98 -106 -114
Accumulated Other Comprehensive Income / (Loss)		 -0.57 -0.76 1.42 -0.35 -1.12 -1.08 -2.45 -2.88 -3.60 -6.54 0.82

Quarterly Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027
Period end date 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025 4/30/2026
Total Assets		 411 476 506 564 624 727 769 792 883 1,051 1,286
Total Current Assets		 365 425 455 514 574 675 717 738 829 997 1,216
Cash & Equivalents		 136 196 205 186 208 233 175 189 178 306 356
Short-Term Investments		 151 121 142 212 209 252 331 357 394 421 618
Accounts Receivable		 38 61 45 50 60 95 132 106 179 170 131
Other Current Assets		 40 47 64 67 98 95 79 85 77 100 112
Plant, Property, & Equipment, net		 11 11 10 11 11 12 14 15 16 16 18
Total Noncurrent Assets		 35 40 40 39 39 40 38 40 38 38 52
Goodwill		 28 28 28 28 28 28 28 28 28 28 28
Intangible Assets		 2.73 2.51 2.41 2.32 2.12 2.02 1.92 1.73 1.63 1.53 1.38
Other Noncurrent Operating Assets		 - 5.88 5.76 5.32 6.80 7.83 6.37 9.81 8.54 8.36 23
Total Liabilities & Shareholders' Equity		 411 476 506 564 624 727 769 792 883 1,051 1,286
Total Liabilities		 139 198 221 279 331 419 440 428 490 631 813
Total Current Liabilities		 135 192 216 274 328 415 436 423 484 620 795
Accounts Payable		 45 36 32 35 66 100 87 69 96 101 124
Accrued Expenses		 40 45 68 83 61 62 78 70 71 67 105
Other Current Liabilities		 49 111 116 156 200 254 271 284 317 452 566
Total Noncurrent Liabilities		 4.62 5.35 5.07 4.93 3.66 3.38 4.00 5.31 5.21 11 18
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - 0.67 0.74 6.12 4.91
Other Noncurrent Operating Liabilities		 - 5.35 5.07 4.93 3.66 3.38 4.00 4.64 4.46 5.18 13
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 272 278 285 285 293 308 329 364 393 420 474
Total Preferred & Common Equity		 273 278 285 285 293 308 329 364 393 420 474
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 273 278 285 285 293 308 329 364 393 420 474
Common Stock		 164 164 165 166 167 168 171 168 169 169 166
Retained Earnings		 198 207 216 217 229 244 266 310 340 364 445
Treasury Stock		 -84 -90 -92 -94 -98 -100 -103 -114 -115 -114 -135
Accumulated Other Comprehensive Income / (Loss)		 -5.05 -2.47 -3.34 -4.65 -5.36 -4.08 -5.70 -0.24 -1.57 -0.11 -2.38

Annual Metrics And Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 13,873,410.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 13,873,410.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 10.46
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 49 76 69 44 -39 22 34 31 24 68 116
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 11.19% 8.29% 19.26% 25.01%
Earnings before Interest and Taxes (EBIT)		 76 115 113 47 -48 25 47 46 49 111 161
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 77 118 116 52 -43 30 51 52 53 117 167
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -56 253 -86 -130 46 170 13 -38 101 120 375
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -53 -230 -76 98 13 -134 -114 -45 -121 -173 -433
Increase / (Decrease) in Invested Capital		 106 -177 155 174 -85 -147 20 69 -77 -52 -259
Book Value per Share		 $14.74 $19.05 $23.03 $25.34 $21.70 $20.44 $20.77 $20.69 $21.83 $25.92 $33.32
Tangible Book Value per Share		 $11.59 $16.24 $20.36 $22.84 $19.59 $18.40 $18.77 $18.43 $19.56 $23.72 $31.19
Total Capital		 222 293 358 394 341 322 326 281 291 352 462
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -275 -523 -434 -297 -328 -457 -440 -325 -412 -525 -895
Capital Expenditures (CapEx)		 3.12 2.81 4.83 8.60 7.06 1.70 1.42 3.37 2.76 6.58 3.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -112 -286 -132 39 -50 -187 -156 -89 -167 -224 -474
Debt-free Net Working Capital (DFNWC)		 163 237 302 335 278 270 284 236 245 301 421
Net Working Capital (NWC)		 163 237 302 335 278 270 284 236 245 301 421
Net Nonoperating Expense (NNE)		 -0.73 -1.54 -3.63 -7.67 1.62 -1.78 -1.94 -3.27 -8.25 -18 -22
Net Nonoperating Obligations (NNO)		 -275 -523 -434 -297 -328 -457 -440 -325 -412 -525 -895
Total Depreciation and Amortization (D&A)		 1.31 3.21 3.81 4.43 4.65 4.62 4.24 5.54 3.92 5.66 6.17
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.46 $4.67 $4.64 $3.34 ($2.73) $1.52 $2.43 $2.35 $2.42 $6.35 $10.00
Adjusted Weighted Average Basic Shares Outstanding		 14.76M 15.07M 15.52M 15.57M 15.62M 15.67M 15.72M 14.08M 13.37M 13.45M 13.77M
Adjusted Diluted Earnings per Share		 $2.42 $4.50 $4.56 $3.32 ($2.73) $1.51 $2.40 $2.33 $2.39 $6.15 $9.74
Adjusted Weighted Average Diluted Shares Outstanding		 15.02M 15.63M 15.78M 15.69M 15.62M 15.83M 15.91M 14.18M 13.55M 13.91M 14.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 14.84M 15.47M 15.57M 15.58M 15.64M 15.72M 14.82M 13.40M 13.24M 13.63M 13.95M
Normalized Net Operating Profit after Tax (NOPAT)		 49 77 69 29 -36 22 40 31 24 68 116
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027
Period end date 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026
DEI Shares Outstanding		 - - - - - - - - - 13,873,410.00 13,945,962.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 13,873,410.00 13,945,962.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 3.61 3.07
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 38.92% 38.54% 52.09% 60.61% 56.95% 41.28% 22.82% 4.73% -2.28% - 50.24%
EBITDA Growth		 8.16% 30.18% 225.84% 38.43% 207.96% 123.41% 152.20% 45.44% 7.10% - 78.34%
EBIT Growth		 12.46% 41.18% 276.60% 39.88% 218.97% 127.55% 163.29% 46.77% 7.34% - 80.52%
NOPAT Growth		 -48.40% -31.51% 78.07% 43.74% 520.20% 219.61% 305.74% 112.54% 9.98% - 111.03%
Net Income Growth		 -29.57% -21.14% 273.73% 42.54% 412.63% 161.02% 186.09% 93.84% 9.74% - 104.27%
EPS Growth		 -28.57% -8.25% 262.50% 39.36% 400.00% 153.93% 175.86% 90.84% 8.50% - 102.50%
Operating Cash Flow Growth		 455.97% -42.71% 1,517.15% 105.29% -44.93% 81.44% 99.55% -52.92% 442.79% - 221.26%
Free Cash Flow Firm Growth		 192.83% 248.72% 470.86% 343.09% -17.19% -8.06% -12.35% -75.12% 76.17% - 358.12%
Invested Capital Growth		 -997.20% -172.58% -216.00% -187.74% -57.59% -42.66% -48.18% -1.36% -72.94% - -173.90%
Revenue Q/Q Growth		 15.85% 0.49% -4.18% 43.97% 13.21% -9.55% -16.70% 22.76% 5.64% - 11.03%
EBITDA Q/Q Growth		 -32.13% 56.63% -32.30% 108.93% 50.99% 13.63% -26.39% 18.27% 10.87% - -1.95%
EBIT Q/Q Growth		 -33.22% 46.44% -33.36% 114.63% 52.29% 4.47% -22.90% 19.64% 11.39% - -2.93%
NOPAT Q/Q Growth		 -61.96% 124.03% -45.27% 208.19% 64.14% 15.45% -30.53% 61.44% -15.06% - -8.18%
Net Income Q/Q Growth		 -57.20% 119.95% -34.42% 130.88% 53.92% 11.99% -28.11% 56.43% -12.86% - -6.40%
EPS Q/Q Growth		 -57.45% 122.50% -34.83% 125.86% 52.67% 13.00% -29.20% 56.25% -13.20% - -6.63%
Operating Cash Flow Q/Q Growth		 61.20% -57.38% -28.09% 315.55% -56.76% 40.42% -20.91% -1.96% 398.51% - -34.21%
Free Cash Flow Firm Q/Q Growth		 263.83% -19.71% 4.17% 45.61% -32.01% -10.85% -0.70% -58.67% 381.49% - 18.09%
Invested Capital Q/Q Growth		 -83.58% -7.80% -1.43% -43.35% -0.55% 2.42% -5.36% 1.94% -71.56% - -15.56%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 11.75% 14.36% 11.38% 13.70% 17.25% 20.48% 19.03% 18.62% 18.69% - 21.00%
EBITDA Margin		 7.44% 11.59% 7.54% 10.94% 14.59% 18.33% 16.20% 15.61% 16.38% - 19.23%
Operating Margin		 4.80% 7.12% 4.13% 8.23% 11.80% 14.05% 12.57% 12.64% 12.99% - 15.60%
EBIT Margin		 7.08% 10.32% 7.17% 10.70% 14.39% 16.62% 15.38% 14.99% 15.80% - 18.48%
Profit (Net Income) Margin		 3.34% 7.30% 5.00% 8.02% 10.90% 13.49% 11.64% 14.84% 12.24% - 15.83%
Tax Burden Percent		 47.13% 70.79% 69.67% 74.95% 75.75% 81.20% 75.71% 98.99% 77.43% - 85.67%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Effective Tax Rate		 52.87% 29.21% 30.33% 25.05% 24.25% 18.80% 24.29% 1.01% 22.57% - 14.33%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Equity (ROE)		 12.79% 11.32% 13.35% 14.69% 21.55% 26.59% 30.48% 33.43% 32.05% - 38.52%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Return on Assets (OROA)		 7.66% 10.88% 8.18% 12.38% 17.41% 20.25% 19.76% 17.15% 15.89% - 18.53%
Return on Assets (ROA)		 3.61% 7.70% 5.70% 9.28% 13.19% 16.45% 14.96% 16.98% 12.31% - 15.87%
Return on Common Equity (ROCE)		 12.80% 11.32% 13.35% 14.69% 21.55% 26.59% 30.48% 33.43% 32.05% - 38.52%
Return on Equity Simple (ROE_SIMPLE)		 12.49% 0.00% 13.01% 14.14% 20.11% 0.00% 27.52% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)		 3.70 8.30 4.54 14 23 27 18 30 25 42 39
NOPAT Margin		 2.26% 5.04% 2.88% 6.17% 8.94% 11.41% 9.52% 12.51% 10.06% - 13.37%
Net Nonoperating Expense Percent (NNEP)		 0.52% 1.01% 0.91% 1.01% 1.11% 1.03% 0.86% 1.05% 0.89% - 0.94%
Return On Investment Capital (ROIC_SIMPLE)		 - 2.85% - - - 7.54% 5.06% 7.57% 6.02% 9.16% 8.21%
Cost of Revenue to Revenue		 88.25% 85.64% 88.62% 86.30% 82.75% 79.52% 80.97% 81.38% 81.31% - 79.00%
SG&A Expenses to Revenue		 6.95% 7.24% 7.25% 5.47% 5.45% 6.43% 6.47% 5.98% 5.70% - 5.40%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Operating Expenses to Revenue		 6.95% 7.24% 7.25% 5.47% 5.45% 6.43% 6.47% 5.98% 5.70% - 5.40%
Earnings before Interest and Taxes (EBIT)		 12 17 11 24 37 39 30 36 40 55 54
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 12 19 12 25 38 43 31 37 41 57 56
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.10 2.00 2.71 3.42 5.42 5.28 5.74 8.50 10.08 - 19.73
Price to Tangible Book Value (P/TBV)		 2.35 2.24 3.02 3.79 5.97 5.77 6.25 9.19 10.84 - 21.04
Price to Revenue (P/Rev)		 1.13 1.02 1.27 1.48 2.21 2.12 2.29 3.63 4.62 - 8.97
Price to Earnings (P/E)		 17.83 18.01 22.10 24.21 27.10 21.73 19.30 27.24 32.92 - 58.71
Dividend Yield		 2.34% 2.52% 1.92% 1.52% 0.97% 0.99% 0.93% 0.61% 0.53% - 0.28%
Earnings Yield		 5.61% 5.55% 4.53% 4.13% 3.69% 4.60% 5.18% 3.67% 3.04% - 1.70%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Revenue (EV/Rev)		 0.38 0.30 0.60 0.80 1.58 1.52 1.69 3.01 3.83 - 8.03
Enterprise Value to EBITDA (EV/EBITDA)		 4.30 3.22 6.35 8.57 13.90 11.40 11.35 18.79 23.33 - 43.76
Enterprise Value to EBIT (EV/EBIT)		 4.56 3.48 6.61 8.87 14.25 11.98 11.89 19.64 24.37 - 45.37
Enterprise Value to NOPAT (EV/NOPAT)		 7.23 7.06 14.44 18.73 25.71 19.65 18.83 28.39 35.07 - 61.47
Enterprise Value to Operating Cash Flow (EV/OCF)		 1.48 1.46 2.79 3.28 8.65 7.95 8.32 18.93 12.20 - 16.98
Enterprise Value to Free Cash Flow (EV/FCFF)		 1.54 1.69 3.43 3.91 11.14 11.14 10.91 27.71 15.27 - 18.45
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Financial Leverage		 -1.22 -1.29 -1.28 -1.40 -1.47 -1.46 -1.47 -1.51 -1.65 - -1.82
Leverage Ratio		 1.75 1.90 1.93 2.08 2.17 2.23 2.16 2.29 2.43 - 2.48
Compound Leverage Factor		 1.75 1.90 1.93 2.08 2.17 2.23 2.16 2.29 2.43 - 2.48
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Altman Z-Score		 3.34 3.21 3.49 3.50 4.56 4.42 5.22 6.28 5.93 - 8.72
Noncontrolling Interest Sharing Ratio		 -0.14% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.88 1.81 1.75 1.63 1.64 1.63 1.75 1.71 1.61 - 1.53
Quick Ratio		 1.63 1.52 1.45 1.40 1.46 1.46 1.54 1.55 1.45 - 1.39
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 106 85 89 129 88 78 78 32 155 302 356
Operating Cash Flow to CapEx		 5,189.75% 4,012.23% 5,492.55% 3,128.78% 1,247.70% 3,269.16% 8,934.94% 2,042.62% 29,587.14% - 4,660.25%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.08 1.05 1.14 1.16 1.21 1.22 1.29 1.14 1.01 - 1.00
Accounts Receivable Turnover		 12.01 11.77 10.39 10.20 8.88 7.84 10.94 6.71 6.06 - 8.78
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Fixed Asset Turnover		 49.56 53.46 58.38 63.22 64.67 68.61 71.84 66.22 61.16 - 63.56
Accounts Payable Turnover		 11.29 10.28 10.56 9.47 11.33 10.72 11.06 7.64 7.87 - 8.53
Days Sales Outstanding (DSO)		 30.38 31.02 35.12 35.80 41.10 46.58 33.38 54.39 60.24 - 41.57
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Days Payable Outstanding (DPO)		 32.34 35.52 34.56 38.56 32.20 34.05 33.01 47.77 46.38 - 42.77
Cash Conversion Cycle (CCC)		 -1.96 -4.50 0.56 -2.76 8.90 12.54 0.36 6.62 13.86 - -1.21
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -113 -121 -123 -177 -178 -173 -183 -179 -307 -433 -500
Invested Capital Turnover		 -8.58 -6.91 -7.74 -5.99 -5.56 -5.93 -5.95 -5.18 -3.78 - -3.05
Increase / (Decrease) in Invested Capital		 -102 -77 -84 -115 -65 -52 -59 -2.40 -130 -259 -317
Enterprise Value (EV)		 201 170 378 569 1,276 1,332 1,541 2,770 3,502 - 8,370
Market Capitalization		 598 583 795 1,054 1,782 1,857 2,088 3,342 4,229 - 9,344
Book Value per Share		 $21.39 $21.83 $22.14 $23.07 $24.35 $25.92 $26.69 $28.82 $30.39 $33.32 $33.95
Tangible Book Value per Share		 $19.11 $19.56 $19.86 $20.82 $22.13 $23.72 $24.51 $26.65 $28.25 $31.19 $31.84
Total Capital		 285 291 293 308 329 352 364 393 420 462 474
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -398 -412 -416 -485 -506 -525 -546 -572 -727 -895 -974
Capital Expenditures (CapEx)		 1.11 0.61 0.32 2.35 2.55 1.37 0.40 1.69 0.58 1.21 2.43
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -157 -167 -170 -225 -225 -224 -231 -228 -350 -474 -552
Debt-free Net Working Capital (DFNWC)		 240 245 247 260 281 301 315 344 377 421 421
Net Working Capital (NWC)		 240 245 247 260 281 301 315 344 377 421 421
Net Nonoperating Expense (NNE)		 -1.76 -3.72 -3.34 -4.20 -5.03 -4.84 -4.12 -5.52 -5.47 -6.86 -7.17
Net Nonoperating Obligations (NNO)		 -398 -412 -416 -485 -506 -525 -546 -572 -727 -895 -974
Total Depreciation and Amortization (D&A)		 0.59 2.10 0.58 0.56 0.53 3.99 1.59 1.47 1.45 1.67 2.18
Debt-free, Cash-free Net Working Capital to Revenue		 -29.82% -29.21% -27.04% -31.54% -27.94% -25.59% -25.42% -24.73% -38.20% - -52.99%
Debt-free Net Working Capital to Revenue		 45.53% 42.72% 39.33% 36.44% 34.85% 34.48% 34.62% 37.41% 41.23% - 40.45%
Net Working Capital to Revenue		 45.53% 42.72% 39.33% 36.44% 34.85% 34.48% 34.62% 37.41% 41.23% - 40.45%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.41 $0.90 $0.59 $1.36 $2.07 $2.33 $1.65 $2.57 $2.22 $3.56 $3.30
Adjusted Weighted Average Basic Shares Outstanding		 13.33M 13.37M 13.26M 13.40M 13.53M 13.45M 13.63M 13.73M 13.83M 13.77M 13.96M
Adjusted Diluted Earnings per Share		 $0.40 $0.89 $0.58 $1.31 $2.00 $2.26 $1.60 $2.50 $2.17 $3.47 $3.24
Adjusted Weighted Average Diluted Shares Outstanding		 13.56M 13.55M 13.57M 13.88M 14.03M 13.91M 14.11M 14.13M 14.16M 14.15M 14.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.33M 13.24M 13.35M 13.50M 13.58M 13.63M 13.64M 13.81M 13.87M 13.95M 14.02M
Normalized Net Operating Profit after Tax (NOPAT)		 5.50 8.30 4.54 14 23 27 18 30 25 42 39
Normalized NOPAT Margin		 3.36% 5.04% 2.88% 6.17% 8.94% 11.41% 9.52% 12.51% 10.06% - 13.37%
Pre Tax Income Margin		 7.08% 10.32% 7.17% 10.70% 14.39% 16.62% 15.38% 14.99% 15.80% - 18.48%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 41.40% 45.38% 40.26% 36.85% 26.11% 21.38% 19.29% 17.45% 18.60% - 16.25%
Augmented Payout Ratio		 79.21% 83.90% 63.78% 50.42% 33.13% 23.16% 27.46% 24.60% 25.21% - 19.96%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways for Argan Inc (NYSE: AGX) based on the last four calendar years of quarterly statements (2023–2026). The focus is on trends in revenue, profitability, cash flow, and balance-sheet strength.

  • Strong top‑line growth and margin expansion in 2025–2026: Revenue rose from roughly 164.6M in Q4 2024 to 232.5–262.1M in 2025–2026 periods, with gross margin improving notably (e.g., gross profit of about 65.6M on 262.1M revenue in Q4 2026, vs substantially lower margins in 2024). This indicates a favorable mix and pricing progression.
  • Higher earnings and EPS in latest quarter: Q4 2026 net income attributable to common shareholders was about 50.1M, with basic EPS of 3.56 and diluted EPS of 3.47. This represents meaningful year‑over‑year earnings growth and improved profitability per share as the company scales.
  • Robust operating cash flow in 2025–2026: Net cash from continuing operating activities was strong in the recent quarters (for example, about 172.3M in Q4 2026 and around 172.5M in Q3 2026), highlighting solid cash generation from core operations.
  • Solid liquidity and a growing equity base: In the latest period, cash and cash equivalents were about 300M+, with ~420M in short‑term investments and total current assets near 1B, while total equity approached 420M. This combination supports balance-sheet resilience and potential capacity for strategic initiatives.
  • Substantial shareholder returns indicated by a quarterly dividend: Cash dividends per share show ongoing distributions (0.50 in Q4 2026, with smaller recent payouts in other quarters), which can be appealing to income‑focused investors when paired with strong earnings growth.
  • Diverse but cyclical capital allocation: 2025–2026 saw notable investing activity (purchases of investments and acquisitions in various quarters), which produced sizable negative cash flows from investing activities in some periods. This suggests a strategic shift toward investment diversification or growth initiatives, but it compresses near‑term free cash flow.
  • Revenue volatility across the four‑year window: After a dip in 2024, revenue recovered by 2025 and continued to grow in 2026, but quarterly results show variability likely tied to product mix or customer cycles. Investors should monitor whether the growth trajectory remains sustainable across demand cycles.
  • Rising near‑term liabilities in mid‑2026: Total current liabilities rose to around 620M by Q3 2026 from lower levels earlier in 2026, signaling increased short‑term obligations that warrant attention for working capital management and liquidity outlook.
  • Financing cash outflows persist in many periods: Net cash from financing activities was negative in several quarters (e.g., Q3 2026 and Q4 2026), reflecting ongoing dividend payments and other financing outflows which may cap cash build‑up from operations alone.
  • Significant investing activity impacting near‑term cash: Net cash from continuing investing activities was negative in several quarters (for example, substantial purchases of investments and acquisitions in 2025–2026), contributing to cash outflows despite strong operating cash flow. This could affect near‑term liquidity depending on investment timing and returns.
06/11/26 08:40 PM ETAI Generated. May Contain Errors.

Argan Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Argan's fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

Argan's net income appears to be on an upward trend, with a most recent value of $137.77 million in 2026, rising from $50.20 million in 2016. The previous period was $85.46 million in 2025. Check out Argan's forecast to explore projected trends and price targets.

Argan's total operating income in 2026 was $134.70 million, based on the following breakdown:
  • Total Gross Profit: $193.68 million
  • Total Operating Expenses: $58.98 million

Over the last 10 years, Argan's total revenue changed from $413.28 million in 2016 to $944.61 million in 2026, a change of 128.6%.

Argan's total liabilities were at $724.09 million at the end of 2026, a 49.5% increase from 2025, and a 285.3% increase since 2016.

In the past 10 years, Argan's cash and equivalents has ranged from $122.11 million in 2018 to $366.67 million in 2021, and is currently $339.48 million as of their latest financial filing in 2026.

Over the last 10 years, Argan's book value per share changed from 14.74 in 2016 to 33.32 in 2026, a change of 126.1%.


Related Companies

Financial statements for NYSE:AGX last updated on 6/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel